EZH2 and metastatic neoplasm: This observation is particularly interesting as prostate metastatic tumors are often osteoblastic (Logothetis and Lin, 2005) and phosphorylation of EZH2 by CDK1 is critical for osteogenic differentiation of human bone-marrow-derived mesenchymal cells (Wei et al., 2011).